Arthritis patients reported less pain and reduced medication use with CBD
In a survey of 428 arthritis patients using CBD, 83% reported pain improvements, with a 44% average pain reduction, and over 60% reduced or stopped other medications including opioids.
Quick Facts
What This Study Found
CBD use was associated with improvements in pain (83%), physical function (66%), and sleep quality (66%). The overall cohort reported a 44% average pain reduction after CBD use. 60.5% of respondents reduced or stopped other medications, including anti-inflammatories (31.1% reduced, 17.8% stopped), acetaminophen (18.2% reduced, 17.8% stopped), and opioids (8.6% reduced, 18.9% stopped). Osteoarthritis patients showed greater improvements than those with rheumatoid or autoimmune arthritis.
Key Numbers
428 respondents. Pain improvement: 83%. Average pain reduction: 44% (p<0.001). Physical function improvement: 66%. Sleep improvement: 66%. Medication reduction/cessation: 60.5%.
How They Did This
Cross-sectional anonymous online survey of 428 self-selected arthritis patients recruited through the Arthritis Foundation, social media, and other channels (May-November 2020). Assessed perceived CBD effects and medication changes.
Why This Research Matters
54 million Americans have arthritis and many rely on medications with significant side effects. CBD's potential to reduce medication dependency, especially opioids, warrants further investigation.
The Bigger Picture
The opioid reduction finding is notable: 8.6% reduced and 18.9% stopped opioids after CBD use. However, as a self-selected survey, these results likely overestimate CBD's effects.
What This Study Doesn't Tell Us
Self-selected convenience sample. No control group. Self-reported outcomes subject to recall and placebo bias. No verification of CBD products used or actual medication changes.
Questions This Raises
- ?Would these results hold in a placebo-controlled trial?
- ?Which CBD formulations and doses are most effective for different types of arthritis?
Trust & Context
- Key Stat:
- 44% average pain reduction; 60% reduced or stopped other medications
- Evidence Grade:
- Self-selected convenience sample with no control group. Useful for hypothesis generation but not for establishing efficacy.
- Study Age:
- Published in 2022.
- Original Title:
- Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study.
- Published In:
- Journal of cannabis research, 4(1), 47 (2022)
- Authors:
- Frane, Nicholas, Stapleton, Erik, Iturriaga, Cesar, Ganz, Maximillian, Rasquinha, Vijay, Duarte, Robert
- Database ID:
- RTHC-03849
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Did CBD help all types of arthritis equally?
No. Osteoarthritis patients reported greater pain reduction than those with rheumatoid arthritis or other autoimmune arthritis, suggesting CBD may be more effective for degenerative than inflammatory joint conditions.
How reliable are these results?
The survey was self-selected (people who chose to respond), had no control group, and relied on self-reported outcomes. Results likely overestimate CBD's effects and need confirmation from controlled clinical trials.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-03849APA
Frane, Nicholas; Stapleton, Erik; Iturriaga, Cesar; Ganz, Maximillian; Rasquinha, Vijay; Duarte, Robert. (2022). Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study.. Journal of cannabis research, 4(1), 47. https://doi.org/10.1186/s42238-022-00154-9
MLA
Frane, Nicholas, et al. "Cannabidiol as a treatment for arthritis and joint pain: an exploratory cross-sectional study.." Journal of cannabis research, 2022. https://doi.org/10.1186/s42238-022-00154-9
RethinkTHC
RethinkTHC Research Database. "Cannabidiol as a treatment for arthritis and joint pain: an ..." RTHC-03849. Retrieved from https://rethinkthc.com/research/frane-2022-cannabidiol-as-a-treatment
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.